NYSE: THCTenet Healthcare Corp Stock
$142.03-0.65 (-0.46%)
Updated Dec 2, 2024
THC Price
$142.03
Fair Value Price
N/A
Market Cap
$13.51B
52 Week Low
$67.78
52 Week High
$171.20
P/E
4.49x
P/B
3.52x
P/S
0.76x
PEG
N/A
Dividend Yield
N/A
Revenue
$20.98B
Earnings
$3.13B
Gross Margin
100%
Operating Margin
24.5%
Profit Margin
14.9%
Debt to Equity
5.56
Operating Cash Flow
$3B
Beta
1.44
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
THC Overview
Tenet Healthcare Corporation is a diversified healthcare services company. Its general hospitals offer acute, intensive, and critical care services, operating and recovery rooms, coronary care units, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides ambulatory surgery and urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. The company was incorporated in 1975 and is headquartered in Dallas, TX.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine THC's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
B
Value
C
Growth
C
Momentum
B
Sentiment
C
Safety
C
Financials
B
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Care Facility
Industry Rating
A
THC
Ranked#11 of 41
Ranked#11 of 41
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $15.01 | A | |
| $127.36 | A | |
| $6.93 | A |
Be the first to know about important THC news, forecast changes, insider trades & much more!
THC News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how THC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
THC is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
THC is good value based on its earnings relative to its share price (4.49x), compared to the US market average (28.28x)
P/E vs Market Valuation
THC is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more THC due diligence checks available for Premium users.
Valuation
THC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
4.49x
Industry
14.03x
Market
28.28x
THC is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
THC is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
THC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.52x
Industry
4.62x
THC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
THC's financial health
Profit margin
Revenue
$5.1B
Net Income
$472.0M
Profit Margin
9.2%
THC's Earnings (EBIT) of $5.14B... subscribe to Premium to read more.
Interest Coverage Financials
THC's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$29.4B
Liabilities
$21.3B
Debt to equity
5.56
THC's short-term assets ($8.76B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
THC's long-term liabilities ($15.76B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
THC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
THC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$1.0B
Investing
$667.0M
Financing
-$498.0M
THC's operating cash flow ($3.20B)... subscribe to Premium to read more.
Debt Coverage Financials
THC vs Medical Care Facility Stocks
Tenet Healthcare Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.